tradingkey.logo
tradingkey.logo
Search

AVITA Medical Inc

RCEL
Add to Watchlist
17.840USD
+1.250+7.54%
Market hours 11/09, 10:20(ET)
551.79MMarket Cap
LossP/E TTM

Today

+7.54%

5 Days

+13.99%

1 Month

+33.83%

6 Months

+334.06%

Year to Date

+417.10%

1 Year

+373.21%

Key Figures

17.200Open
18.070High
9.03KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.03%Turnover Ratio
16.590Prev. Close
15.920Low
156.77KTurnover
LossP/E Static
-17.78P/B
0.00%Div Yield TTM
-74.88%ROA
18.07052wk High
0.10Volume Ratio
-61.84MNet Profit
30.93MShares
-1.5635EPS TTM
1.88Beta
-1746.27%ROE
3.22052wk Low
12.96%Amplitude
84.02%Gross Margin
551.79MMarket Cap
11.20Reward/Risk
5.99%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

AVITA Medical Inc's Score

0.21vs previous score
Forecast7.00
Financial Health7.84
Technical5.32
Valuation Dimensions9.37
Institutional Confidence3.00
Risk Assessment4.63

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
13.667Target Price
-12.67%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy11011111
Buy22223333
Hold00211222
Sell00000000
Strong Sell11000000

AVITA Medical Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Strong buy
Summary
Buy
Moving Average
Strong buy

AVITA Medical Inc Latest Earnings Call Transcripts

AVITA Medical (RCEL) Q3 2026 Earnings Call: Guidance Raised as Revenue Grows 53%

AVITA Medical’s Q3 2026 earnings call covered 53% revenue growth, an 84% gross margin, lower cash use and raised 2026 revenue guidance of $92 million-$94 million.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.20/-0.22
Revenue / Forecast
26.11M/22.20M

AVITA Medical Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolRCEL
Number of employees260
CountryUnited States of America

Ownership

ShareholdersProportion
Vanguard Capital Management, LLC4.34%
BlackRock Institutional Trust Company, N.A.3.28%
Geode Capital Management, L.L.C.1.56%
State Street Investment Management (US)1.36%
Shareholder TypesProportion
Investment Advisor10.66%
Investment Advisor/Hedge Fund4.72%
Individual Investor0.96%
Research Firm0.60%

FAQs

What is the current price of AVITA Medical Inc (RCEL)?

The current price of AVITA Medical Inc (RCEL) is 16.59.

What is the symbol of AVITA Medical Inc?

The ticker symbol of AVITA Medical Inc is RCEL.

What is the 52-week high of AVITA Medical Inc?

The 52-week high of AVITA Medical Inc is 18.07.

What is the 52-week low of AVITA Medical Inc?

The 52-week low of AVITA Medical Inc is 3.22.

What is the market capitalization of AVITA Medical Inc?

The market capitalization of AVITA Medical Inc is 513.13M.

Is AVITA Medical Inc (RCEL) currently rated as Buy, Hold, or Sell?

According to analysts, AVITA Medical Inc (RCEL) has an overall rating of Buy, with a price target of 13.67.

What is the Earnings Per Share (EPS TTM) of AVITA Medical Inc (RCEL)?

The Earnings Per Share (EPS TTM) of AVITA Medical Inc (RCEL) is -1.56.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.